Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
CALL
Vanguard Morningstar Growth ETF
VUG
$230B
| $647K | ﹤0.01% |
27,600
+6,000
| +28% | +$138K |
|
|
APU
5127
PUT
DELISTED
AmeriGas Partners, L.P.
APU
| $647K | ﹤0.01% |
+14,000
| New | +$630K |
|
|
ZNGA
5128
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $646K | ﹤0.01% |
161,500
+21,400
| +15% | +$83.4K |
|
|
GNBC
5129
DELISTED
Green Bancorp, Inc
GNBC
| $646K | ﹤0.01% |
31,827
-127
| -0.4% | -$2.82K |
|
|
WLH
5130
CALL
DELISTED
WILLIAM LYON HOMES
WLH
| $646K | ﹤0.01% |
22,200
+100
| +0.5% | +$2.71K |
|
5131
PUT
EPAM Systems
EPAM
$5.03B
| $645K | ﹤0.01% |
6,000
+3,200
| +114% | +$317K |
|
5132
PUT
Alaunos Therapeutics
TCRT
$4.86M
| $645K | ﹤0.01% |
1,039
+217
| +26% | +$156K |
|
5133
CALL
iShares US Basic Materials ETF
IYM
$1.02B
| $644K | ﹤0.01% |
6,300
+800
| +15% | +$79.4K |
|
5134
Corcept Therapeutics
CORT
$12B
| $643K | ﹤0.01% |
35,576
-96,260
| -73% | -$1.74M |
|
5135
Aegon
AEG
$14.1B
| $642K | ﹤0.01% |
125,222
+47,258
| +61% | +$230K |
|
5136
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $642K | ﹤0.01% |
+9,200
| New | +$628K |
|
|
SPPI
5137
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $642K | ﹤0.01% |
+33,900
| New | +$614K |
|
|
MCRN
5138
DELISTED
Milacron Holdings Corp.
MCRN
| $642K | ﹤0.01% |
33,544
-223,346
| -87% | -$3.99M |
|
|
EGC
5139
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $642K | ﹤0.01% |
111,792
-1,033
| -0.9% | -$7.27K |
|
5140
PUT
Amphenol
APH
$209B
| $641K | ﹤0.01% |
29,200
+14,000
| +92% | +$308K |
|
5141
PUT
Franklin Covey
FC
$246M
| $641K | ﹤0.01% |
30,900
+10,700
| +53% | +$210K |
|
5142
PJT Partners
PJT
$4.38B
| $641K | ﹤0.01% |
+14,064
| New | +$572K |
|
5143
CALL
Shutterstock
SSTK
$219M
| $641K | ﹤0.01% |
+14,900
| New | +$581K |
|
5144
CALL
Novanta
NOVT
$6.29B
| $640K | ﹤0.01% |
12,800
-100
| -0.8% | -$4.87K |
|
|
ESGF
5145
DELISTED
Oppenheimer Global ESG Revenue ETF
ESGF
| $640K | ﹤0.01% |
+20,403
| New | +$640K |
|
5146
IDT Corp
IDT
$1.62B
| $639K | ﹤0.01% |
71,237
+18,279
| +35% | +$200K |
|
5147
PUT
Sensata Technologies
ST
$6.79B
| $639K | ﹤0.01% |
+12,500
| New | +$616K |
|
5148
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
| $638K | ﹤0.01% |
15,038
-8,203
| -35% | -$344K |
|
5149
UDR
UDR
$12.3B
| $638K | ﹤0.01% |
16,570
-206,897
| -93% | -$8.04M |
|
|
TBRG
5150
DELISTED
TruBridge
TBRG
| $638K | ﹤0.01% |
21,243
+6,533
| +44% | +$194K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.